
Sun Pharmaceutical Industries Ltd. (SUNPHARMA): Sun Pharmaceutical Industries Share Price rises 2.53% as stock gains today
Updated: 21 Sept 2026 • 10:06 am
Posted by:

Sun Pharmaceutical Industries Share Price rose today, with the stock closing at Rs 1,881.95 after a 2.53% gain from the previous close of Rs 1,835.50. The move added Rs 46.45 and lifted market capitalisation to Rs 4,40,397.93 cr. In this Sun Pharmaceutical Industries Share Price update, the verified data confirms a clear same-day price rise, while it does not establish a company-specific catalyst. For investors tracking Sun Pharmaceutical Industries Stock News, the immediate focus is on the recorded price action, the stock’s premium valuation versus the broader Pharmaceuticals & Drugs set, and whether the current move is supported by the company’s financial profile. Univest is tracking the stock through a factual, market-led lens that combines price, fundamentals and sector context.
The move also places Sun Pharmaceutical Industries Share Price in the day’s active news flow across the Indian Stock Market, where same-session share price rise stories often attract search interest. Univest’s analysis below keeps to verified data only, without turning the move into a causal claim.
Sun Pharmaceutical Industries Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,881.95 |
| Previous Close | Rs 1,835.5 |
| Today's Move | Rs 46.45 (+2.53%) |
| Open | Rs 1,837 |
| High | Rs 1,882.3 |
| Low | Rs 1,835.5 |
| Turnover | Rs 1.83 crore |
| Market Capitalisation | Rs 4,40,397.93 crore |
| Market Cap Category | Large Cap |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) rose to Rs 1,881.95 from the previous close of Rs 1,835.5, a move of Rs 46.45 or 2.53%. The stock opened at Rs 1,837, reached a high of Rs 1,882.3, recorded a low of Rs 1,835.5.
Sun Pharmaceutical Industries Share Price started the session at Rs 1,837.00, matched the day’s low of Rs 1,835.50 and finished near the high of Rs 1,882.30. The current price of Rs 1,881.95 is Rs 46.45 above the previous close, and the day’s range shows the stock held firm around the upper end of the session. Turnover stood at Rs 1.83 cr. These facts confirm the share price rise in Sun Pharmaceutical Industries Share News today, but they do not by themselves explain why the move happened.
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,40,397.93 crore |
| P/E Ratio | 36.41x |
| P/B Ratio | 5.09x |
| ROE | 14.85% |
| ROCE | 19.11% |
| EPS | Rs 50.41 |
| Book Value Per Share | Rs 360.44 |
| Dividend Yield | 0.87% |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) fundamental metrics show P/E 36.41x, P/B 5.09x, ROE 14.85%, ROCE 19.11%. These figures provide context only and are not a buy or sell signal.
Sun Pharmaceutical Industries Ltd. has a market capitalisation of Rs 440397.93 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 36.41x, P/B at 5.09x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.85% and ROCE of 19.11%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 50.41, book value per share of Rs 360.44, dividend yield of 0.87%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 36.41x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 48.77x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 5.09x |
| Benchmark Median P/B | 3.08x |
| Company ROE | 14.85% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 19.11% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 4,40,397.93 crore |
| Benchmark Median Market Cap | Rs 701.78 crore |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a P/E ratio of 36.41x, which is above the benchmark median of 32.87x, a difference of +10.77%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a ROE of 14.85%, which is above the benchmark median of 11.7%, a difference of +26.92%. Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a ROCE of 19.11%, which is above the benchmark median of 13.46%, a difference of +41.98%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.01 | 14.08 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 83.79 | 20.36 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.48 | 4.27 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 32.87 | 3.15 | 11.83 | 16 |
| Laurus Labs Ltd. | LAURUSLABS | 1,05,644.55 | 96.62 | 18.73 | 18.31 | 18.2 |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a P/E ratio of 36.41x compared with the displayed peer median of 83.79x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.85% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 19.11% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a market capitalisation of Rs 4,40,397.93 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Sun Pharmaceutical Industries
- Sun Pharmaceutical Industries Share Price rose 2.53% today to Rs 1,881.95.
- The stock added Rs 46.45 from the previous close of Rs 1,835.50.
- Market capitalisation stands at Rs 4,40,397.93 cr.
- P/E is 36.41, P/B is 5.09, ROE is 14.85% and ROCE is 19.11%.
- In the same-industry benchmark, Sun Pharmaceutical Industries Share Price trades above the median P/E and P/B, while ROE and ROCE also sit above the median.
About Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The available data identifies the company through its listed market profile on NSE and BSE, and the current share price behaviour shows how it is being tracked by market participants today. As a large listed pharmaceutical business by market capitalisation, Sun Pharmaceutical Industries Share Price often draws attention in stock market news because the company sits inside a broad industry benchmark of 204 firms. In practical terms, the company’s business is tied to the pharmaceutical value chain, and its market reading is shaped by financial results, valuation multiples and peer comparison rather than by today’s price move alone. Univest uses this section to keep the company overview factual and search-friendly for readers looking for Sun Pharmaceutical Industries Latest News, Sun Pharmaceutical Industries Company News and Sun Pharmaceutical Industries Stock Performance.
For readers searching Sun Pharmaceutical Industries Share Price Live or Sun Pharmaceutical Industries Share Price Today, the company’s profile is best understood as a mix of scale, valuation and industry positioning. The move today is one part of that picture, not the entire story.
Track Sun Pharmaceutical Industries Share Price on Univest
Use Sun Pharmaceutical Industries Ltd. (SUNPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Sun Pharmaceutical Industries Share Price rise today?
Ans. The verified data confirms a 2.53% rise to Rs 1,881.95, but it does not establish a company-specific catalyst. The move is visible in the session’s price action and market-cap update.
What is Sun Pharmaceutical Industries Share Price today?
Ans. Sun Pharmaceutical Industries Share Price today is Rs 1,881.95, compared with the previous close of Rs 1,835.50. The stock gained Rs 46.45 in the session and finished near the day’s high.
How much did Sun Pharmaceutical Industries stock gain today?
Ans. Sun Pharmaceutical Industries stock gained Rs 46.45, which equals 2.53% for the day. The rise came from a Rs 1,837.00 open and a close of Rs 1,881.95. The previous close was Rs 1,835.5.
What is the market capitalisation of Sun Pharmaceutical Industries?
Ans. Sun Pharmaceutical Industries has a market capitalisation of Rs 4,40,397.93 cr. That figure places it far above the same-industry median of Rs 701.78 cr in the supplied benchmark set. The company operates in the Healthcare sector.
How does Sun Pharmaceutical Industries compare on valuation?
Ans. Sun Pharmaceutical Industries Share Price reflects a P/E of 36.41 and a P/B of 5.09. Both are above the same-industry medians of 32.87 and 3.08, respectively, in the supplied benchmark.
What do Sun Pharmaceutical Industries ROE and ROCE show?
Ans. ROE is 14.85% and ROCE is 19.11%. Both are above the sector medians of 11.7% and 13.46%, which gives useful context for Sun Pharmaceutical Industries Fundamental Analysis. ROE stands at 14.85%.
How does Sun Pharmaceutical Industries compare with peers?
Ans. Compared with peers, Sun Pharmaceutical Industries trades below Divi's Laboratories and Torrent Pharmaceuticals on P/E, but above Zydus Lifesciences and Cipla. Its ROCE is also competitive within the peer set.
Where can I track Sun Pharmaceutical Industries Share Price live?
Ans. You can track Sun Pharmaceutical Industries Share Price on Univest for live pricing, valuation ratios, sector comparison and market insights. The company page also helps readers follow stock news in one place.
Recent Articles

Gujarat Gas (GUJENERGY) Share Price falls 2.1% to Rs 240.15 today
21 September 2026

Tarsons Products Ltd. (TARSONS): Tarsons Products Share Price Rises 10.55% as Stock Gains Today
21 September 2026

Ratnamani Metals & Tubes (RATNAMANI) Share Price Falls 2.16% Today
21 September 2026

Crown Lifters Ltd. (CROWN): Crown Lifters Share Price rises 10.62% to Rs 120: what the data shows
21 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Gujarat Gas (GUJENERGY) Share Price falls 2.1% to Rs 240.15 today
Tarsons Products Ltd. (TARSONS): Tarsons Products Share Price Rises 10.55% as Stock Gains Today
Ratnamani Metals & Tubes (RATNAMANI) Share Price Falls 2.16% Today
Crown Lifters Ltd. (CROWN): Crown Lifters Share Price rises 10.62% to Rs 120: what the data shows
Bikewo Green Tech Ltd. Hits Upper Circuit on NSE, 21 September 2026
Popular this week
SAL Steel Ltd. (SALSTEEL): SAL Steel Share Price Near 52-Week High After 3.33% Rise

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





